Sidley Represents Vivo Capital on Its Acquisition of Dutscher Group

Sidley is representing Vivo Capital, a leading global investment firm focused exclusively on healthcare and life sciences, on the acquisition of Dutscher Group, the European leader in consumables and equipment distribution for R&D laboratories. Following a successful consultation process, Dutscher’s employee representative bodies have rendered a favourable opinion on the transaction, which is expected to close during the first half of 2026, subject to regulatory approvals.

The deal will mark Vivo Capital’s first buyout investment in Europe and underscores the firm’s continued expansion as a global healthcare investor, building on its long-standing leadership across North America and Asia.

The Sidley team is being led by Robert Darwin and Ruchun Ji (M&A & Private Equity), and it includes Josefine Sommer (Food, Drug and Medical Device), Jason Menzies (Tax), Tanya Indisova, Pedro Sacadura Botte, Nicolas Gomez Ospina (M&A & Private Equity), Anne Robert (Antitrust and Competition), and Alessandra Moroni (Global Arbitration, Trade and Advocacy).